STAT+: Roche to launch another Elevidys trial, with eyes on European approval

RFK Jr.'s testimony to Congress, broader access to peptides, and more health news from Morning Rounds

How a rare disease drugmaker won FDA approval after a clinical trial disappointed.

RFK Jr. has a delicate task ahead of him as he faces a marathon of hearings on Capitol Hill.

The debate about AI and mental health has so far focused on content. But the way the content is delivered matters, too.